Good Manufacturing Practice-Derived Human Liver Stem Cell Extracellular Vesicles Attenuate Liver Fibrosis In Vivo
Authors:
- Elena CeccottiECElena Ceccotti
- Veronica DimuccioVDVeronica Dimuccio
- Chiara PasquinoCPChiara Pasquino
- Massimo CedrinoMCMassimo Cedrino
- Maria Beatriz Herrera SanchezMaria Beatriz Herrera Sanchez
- Cristina GrangeCristina Grange
- Federico FiglioliniFFFederico Figliolini
- Giorgio NicolòGNGiorgio Nicolò
- Federica AnticoFAFederica Antico
- Selene LimoncelliSLSelene Limoncelli
- Giulio MengozziGMGiulio Mengozzi
- Giulia GioielloGiulia Gioiello
Open Access
Abstract
Human liver stem cells (HLSCs) are a mesenchymal stromal cell (MSC)-like population isolated from adult liver biopsies. HLSCs share key characteristics with MSCs, including phenotype and differentiation capabilities. Previous studies have demonstrated that HLSCs promote regeneration in different experimental models of acute and chronic tissue injury and that HLSC-derived extracellular vesicles (HLSC-EVs) recapitulate the therapeutic effects of the cells of origin. This study aimed to determine whether HLSC-EVs, obtained and characterized under good manufacturing practice (GMP) conditions, can influence the progression of liver fibrosis in vivo. The EV production process was carried out under GMP conditions to generate batches of HLSC-EVs by tangential flow filtration. To assess their therapeutic potential, an in vivo model of hepatic fibrosis was established through administration of thioacetamide (TAA). In TAA-treated mice, EV administrations attenuated fibrosis progression. Molecular analyses showed a significant reduction in the expression levels of key pro-fibrotic genes. At the functional level, EV administration resulted in a significant reduction in plasma alanine aminotransferase levels and an increase in albumin levels, indicating improved liver function. These data indicate that HLSC-EVs, produced under GMP conditions, display antifibrotic effects in a chronic liver disease model, leading to improved liver function and histology.Keywords
Funding Information
- Unicyte AG
This publication has 27 references indexed in Scilit:
- First‐In‐Human Application of Human Umbilical Cord‐Derived Extracellular Vesicles in Tethered Spinal Cord Release SurgeryJournal of Extracellular Vesicles, 2025
- Global requirements for manufacturing and validation of clinical grade extracellular vesiclesThe Journal of Liquid Biopsy, 2024
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Scaled preparation of extracellular vesicles from conditioned mediaAdvanced Drug Delivery Reviews, 2021
- First‐in‐human intracochlear application of human stromal cell‐derived extracellular vesiclesJournal of Extracellular Vesicles, 2021
- Infusion of Human Mesenchymal Stem Cells Improves Regenerative Niche in Thioacetamide-Injured Mouse LiverTissue Engineering and Regenerative Medicine, 2020
- Intrahepatic Administration of Human Liver Stem Cells in Infants with Inherited Neonatal-Onset Hyperammonemia: A Phase I StudyStem Cell Reviews and Reports, 2019
- Transplantation of human adipose tissue derived-SVF enhance liver function through high anti-inflammatory propertyBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2019
- Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issuesMolecular Aspects of Medicine, 2019
- Exosomes Produced from 3D Cultures of MSCs by Tangential Flow Filtration Show Higher Yield and Improved ActivityMolecular Therapy, 2018